Stockreport

Evercore Downgrades Intellia (NTLA) Despite Strong ATTR Trial Data [Yahoo! Finance]

Evercore Inc. Class A  (EVR) 
Last evercore inc. class a earnings: 4/22 06:00 am Check Earnings Report
PDF 11, Evercore ISI downgraded Intellia Therapeutics (NASDAQ:NTLA) from Outperform to In Line and cut its price target to $8 from $17, citing uncertainty around the company [Read more]